We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$560M
AUM Growth
-$74.7M
Cap. Flow
-$79.7M
Cap. Flow %
-14.23%
Top 10 Hldgs %
44.6%
Holding
340
New
9
Increased
8
Reduced
106
Closed
11

Top Buys

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$1.29M
2
S icon
SentinelOne
S
+$1.15M
3
TSLA icon
Tesla
TSLA
+$1.08M
4
SPGI icon
S&P Global
SPGI
+$915K
5
UPS icon
United Parcel Service
UPS
+$856K

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.47M
2
AAPL icon
Apple
AAPL
+$8.37M
3
AMZN icon
Amazon
AMZN
+$5.31M
4
EQIX icon
Equinix
EQIX
+$3.27M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.15M

Sector Composition

Rank Sector Weight
1 Technology 31.93%
2 Healthcare 14.26%
3 Consumer Discretionary 14.14%
4 Financials 13.68%
5 Communication Services 12.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FORM icon
126
FormFactor
FORM
$8.28B
$461K 0.08%
12,342
– –
NVCR icon
127
NovoCure
NVCR
$1.73B
$440K 0.08%
3,788
– –
RH icon
128
RH
RH
$3.13B
$440K 0.08%
660
– –
MCRI icon
129
Monarch Casino & Resort
MCRI
$2.2B
$436K 0.08%
6,506
– –
WDFC icon
130
WD-40
WDFC
$3.05B
$430K 0.08%
1,859
– –
COUP
131
DELISTED
Coupa Software Incorporated
COUP
$404K 0.07%
1,843
-510
-22% -$120K
JNJ icon
132
Johnson & Johnson
JNJ
$618B
$399K 0.07%
2,471
– –
SRPT icon
133
Sarepta Therapeutics
SRPT
$1.57B
$396K 0.07%
4,287
– –
ROST icon
134
Ross Stores
ROST
$80.5B
$394K 0.07%
3,621
-850
-19% -$102K
RLI icon
135
RLI Corp
RLI
$5.62B
$384K 0.07%
7,668
– –
AGYS icon
136
Agilysys
AGYS
$2.97B
$378K 0.07%
7,226
– –
LAD icon
137
Lithia Motors
LAD
$8.47B
$378K 0.07%
1,193
– –
PLNT icon
138
Planet Fitness
PLNT
$4.42B
$353K 0.06%
4,492
– –
TENB icon
139
Tenable Holdings
TENB
$3.6B
$352K 0.06%
7,624
– –
PG icon
140
Procter & Gamble
PG
$336B
$351K 0.06%
2,513
– –
RETA
141
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$350K 0.06%
3,483
– –
MSA icon
142
Mine Safety
MSA
$7.35B
$345K 0.06%
2,366
– –
BL icon
143
BlackLine
BL
$1.84B
$333K 0.06%
2,820
+1,479
+110% +$170K
BILL icon
144
BILL Holdings
BILL
$4.49B
$332K 0.06%
1,245
– –
MGNI icon
145
Magnite
MGNI
$2.76B
$331K 0.06%
11,818
-9,379
-44% -$282K
DIN icon
146
Dine Brands
DIN
$456M
$328K 0.06%
4,037
+1,847
+84% +$149K
UNP icon
147
Union Pacific
UNP
$174B
$325K 0.06%
1,657
– –
RARE icon
148
Ultragenyx Pharmaceutical
RARE
$2.45B
$323K 0.06%
3,578
– –
EVBG
149
DELISTED
Everbridge, Inc. Common Stock
EVBG
$320K 0.06%
2,118
-1,022
-33% -$151K
CDLX icon
150
Cardlytics
CDLX
$21.7M
$316K 0.06%
377
-243
-39% -$247K
4 5
6
7 8

Similar funds

AG
Ascent Group Virginia Beach, Virginia $2.89B AUM 19.6% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
PFM
Potomac Fund Management Miami, Florida $2.88B AUM 15.75% 1-Year Est. Return
DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $2.88B AUM 18.53% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return
CCM
Chilton Capital Management Houston, Texas $2.87B AUM 25.44% 1-Year Est. Return
HCC
Hirtle Callaghan & Co West Conshohocken, Pennsylvania $2.92B AUM 17.65% 1-Year Est. Return

Silvant Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Silvant Capital Management held 340 positions worth $560M, down 12% from $635M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Silvant Capital Management withdrew a net $79.7M in Q3 2021, closing 11 positions and reducing 106 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Silvant Capital Management opened a new position in SentinelOne worth $1.13M.

  • Silvant Capital Management's largest Q3 2021 buy was SentinelOne: 21,028 shares worth $1.13M.
  • Silvant Capital Management added most to DraftKings in Q3 2021, an estimated $1.29M increase.
  • Silvant Capital Management's biggest Q3 2021 reduction was Microsoft, cutting an estimated $8.47M.
  • Silvant Capital Management fully exited Vertex Pharmaceuticals in Q3 2021, selling an estimated $2.16M.
  • Silvant Capital Management's ten largest holdings make up 45% of its $560M portfolio in Q3 2021.
  • Silvant Capital Management opened 9 new positions and closed 11 in Q3 2021.
  • Silvant Capital Management's portfolio value fell 12% quarter-over-quarter to $560M.

Based on Silvant Capital Management's 13F filing for Q3 2021, filed 8 Nov 2021.